

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 7.62210167 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.07127588 |
| 3 | negative regulation of cell killing (GO:0031342) | 6.07127588 |
| 4 | neutrophil activation involved in immune response (GO:0002283) | 5.92262892 |
| 5 | ribosomal small subunit assembly (GO:0000028) | 5.59188707 |
| 6 | response to peptidoglycan (GO:0032494) | 4.70051574 |
| 7 | response to interferon-beta (GO:0035456) | 4.62077082 |
| 8 | detection of bacterium (GO:0016045) | 4.61317608 |
| 9 | negative regulation of interleukin-12 production (GO:0032695) | 4.56899401 |
| 10 | mature B cell differentiation involved in immune response (GO:0002313) | 4.54130225 |
| 11 | viral transcription (GO:0019083) | 4.41566150 |
| 12 | immunoglobulin mediated immune response (GO:0016064) | 4.27868960 |
| 13 | macrophage activation involved in immune response (GO:0002281) | 4.24287815 |
| 14 | response to interferon-alpha (GO:0035455) | 4.21629595 |
| 15 | respiratory burst (GO:0045730) | 4.18672771 |
| 16 | regulation of gamma-delta T cell activation (GO:0046643) | 4.17819084 |
| 17 | translational termination (GO:0006415) | 4.17153131 |
| 18 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.14556275 |
| 19 | eosinophil chemotaxis (GO:0048245) | 4.14043632 |
| 20 | detection of external biotic stimulus (GO:0098581) | 4.13369023 |
| 21 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.07120752 |
| 22 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.07120752 |
| 23 | modulation by symbiont of host immune response (GO:0052553) | 4.07120752 |
| 24 | positive regulation by symbiont of host defense response (GO:0052509) | 4.07120752 |
| 25 | modulation by symbiont of host defense response (GO:0052031) | 4.07120752 |
| 26 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.07120752 |
| 27 | platelet dense granule organization (GO:0060155) | 4.04932991 |
| 28 | mature B cell differentiation (GO:0002335) | 4.01181212 |
| 29 | granulocyte activation (GO:0036230) | 4.00364571 |
| 30 | myeloid cell activation involved in immune response (GO:0002275) | 4.00326447 |
| 31 | detection of molecule of bacterial origin (GO:0032490) | 3.96209190 |
| 32 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.93138069 |
| 33 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.92460253 |
| 34 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.90962723 |
| 35 | eosinophil migration (GO:0072677) | 3.88796666 |
| 36 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.86258523 |
| 37 | neutrophil activation (GO:0042119) | 3.85040775 |
| 38 | endosome to pigment granule transport (GO:0043485) | 3.77592761 |
| 39 | endosome to melanosome transport (GO:0035646) | 3.77592761 |
| 40 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.74180362 |
| 41 | definitive hemopoiesis (GO:0060216) | 3.73527864 |
| 42 | detection of biotic stimulus (GO:0009595) | 3.70723515 |
| 43 | negative regulation of T cell mediated immunity (GO:0002710) | 3.69654214 |
| 44 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.67434303 |
| 45 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.66860607 |
| 46 | defense response to protozoan (GO:0042832) | 3.64262692 |
| 47 | mast cell activation (GO:0045576) | 3.63820642 |
| 48 | type I interferon signaling pathway (GO:0060337) | 3.63516578 |
| 49 | cellular response to type I interferon (GO:0071357) | 3.63516578 |
| 50 | response to type I interferon (GO:0034340) | 3.60204981 |
| 51 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.59714017 |
| 52 | positive regulation of interferon-alpha production (GO:0032727) | 3.58805019 |
| 53 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.57534922 |
| 54 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.55966307 |
| 55 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.55966307 |
| 56 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.54212964 |
| 57 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.53257954 |
| 58 | response to protozoan (GO:0001562) | 3.51048519 |
| 59 | cotranslational protein targeting to membrane (GO:0006613) | 3.46726215 |
| 60 | ribosomal small subunit biogenesis (GO:0042274) | 3.46297519 |
| 61 | regulation of mast cell degranulation (GO:0043304) | 3.45713134 |
| 62 | protein targeting to ER (GO:0045047) | 3.45607758 |
| 63 | regulation of leukocyte degranulation (GO:0043300) | 3.44536100 |
| 64 | positive regulation of B cell differentiation (GO:0045579) | 3.44455802 |
| 65 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.44312854 |
| 66 | regulation of MHC class II biosynthetic process (GO:0045346) | 3.42714434 |
| 67 | T-helper 1 type immune response (GO:0042088) | 3.41180235 |
| 68 | response to interleukin-15 (GO:0070672) | 3.40707038 |
| 69 | microglial cell activation (GO:0001774) | 3.40703725 |
| 70 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.40545930 |
| 71 | translational elongation (GO:0006414) | 3.39592937 |
| 72 | regulation of interferon-alpha production (GO:0032647) | 3.39115564 |
| 73 | positive regulation of macrophage differentiation (GO:0045651) | 3.38585584 |
| 74 | neutrophil mediated immunity (GO:0002446) | 3.38522126 |
| 75 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.37393456 |
| 76 | leukocyte degranulation (GO:0043299) | 3.36367097 |
| 77 | tolerance induction (GO:0002507) | 3.35614454 |
| 78 | myeloid dendritic cell activation (GO:0001773) | 3.33050243 |
| 79 | regulation of mast cell activation (GO:0033003) | 3.32475494 |
| 80 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.31408987 |
| 81 | B cell mediated immunity (GO:0019724) | 3.30775978 |
| 82 | cellular response to interleukin-15 (GO:0071350) | 3.30098514 |
| 83 | phagocytosis, engulfment (GO:0006911) | 3.29691108 |
| 84 | monocyte chemotaxis (GO:0002548) | 3.29362779 |
| 85 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.28138197 |
| 86 | protein localization to endoplasmic reticulum (GO:0070972) | 3.27257828 |
| 87 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.26608708 |
| 88 | positive regulation of antigen processing and presentation (GO:0002579) | 3.26447198 |
| 89 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.18699604 |
| 90 | negative regulation of viral genome replication (GO:0045071) | 3.18252280 |
| 91 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.17098108 |
| 92 | viral life cycle (GO:0019058) | 3.17079569 |
| 93 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.16221542 |
| 94 | response to host (GO:0075136) | 3.16221542 |
| 95 | response to host defenses (GO:0052200) | 3.16221542 |
| 96 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.16084752 |
| 97 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.15356594 |
| 98 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.13798081 |
| 99 | myeloid dendritic cell differentiation (GO:0043011) | 3.13088009 |
| 100 | regulation of tolerance induction (GO:0002643) | 3.12828288 |
| 101 | positive regulation of lymphocyte migration (GO:2000403) | 3.12554920 |
| 102 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.12150239 |
| 103 | regulation of T cell tolerance induction (GO:0002664) | 3.11562992 |
| 104 | germinal center formation (GO:0002467) | 3.10452788 |
| 105 | cellular extravasation (GO:0045123) | 3.09374970 |
| 106 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.09004219 |
| 107 | macrophage activation (GO:0042116) | 3.08708981 |
| 108 | T cell migration (GO:0072678) | 3.08545936 |
| 109 | pinocytosis (GO:0006907) | 3.08346623 |
| 110 | cellular response to interferon-beta (GO:0035458) | 3.06142137 |
| 111 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.05935452 |
| 112 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.04871139 |
| 113 | positive regulation of mast cell degranulation (GO:0043306) | 3.04871139 |
| 114 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.04247800 |
| 115 | positive thymic T cell selection (GO:0045059) | 3.04227002 |
| 116 | myeloid leukocyte activation (GO:0002274) | 3.03874268 |
| 117 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.01005585 |
| 118 | negative thymic T cell selection (GO:0045060) | 2.99985668 |
| 119 | regulation of B cell differentiation (GO:0045577) | 2.99967625 |
| 120 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.99671631 |
| 121 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.98586823 |
| 122 | B cell receptor signaling pathway (GO:0050853) | 2.96902731 |
| 123 | cellular protein complex disassembly (GO:0043624) | 2.96769688 |
| 124 | positive regulation of interleukin-17 production (GO:0032740) | 2.93690415 |
| 125 | negative regulation of interleukin-6 production (GO:0032715) | 2.93433089 |
| 126 | myeloid leukocyte mediated immunity (GO:0002444) | 2.92895898 |
| 127 | regulation of regulated secretory pathway (GO:1903305) | 2.92579561 |
| 128 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.92446391 |
| 129 | negative T cell selection (GO:0043383) | 2.91948955 |
| 130 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.91867760 |
| 131 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.91366553 |
| 132 | positive regulation of mast cell activation (GO:0033005) | 2.90604242 |
| 133 | maturation of SSU-rRNA (GO:0030490) | 2.90453705 |
| 134 | megakaryocyte development (GO:0035855) | 2.89235263 |
| 135 | neutrophil chemotaxis (GO:0030593) | 2.89187673 |
| 136 | negative regulation of phagocytosis (GO:0050765) | 2.88869248 |
| 137 | lymphocyte chemotaxis (GO:0048247) | 2.88361787 |
| 138 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.87762190 |
| 139 | response to host immune response (GO:0052572) | 2.87762190 |
| 140 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.86922865 |
| 141 | detection of other organism (GO:0098543) | 2.86547955 |
| 142 | response to muramyl dipeptide (GO:0032495) | 2.85284452 |
| 143 | leukocyte aggregation (GO:0070486) | 2.84690339 |
| 144 | regulation of antigen processing and presentation (GO:0002577) | 2.83200634 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.98985632 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.42059411 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.30130971 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.25586940 |
| 5 | SCL_19346495_ChIP-Seq_HPC-7_Human | 4.15368914 |
| 6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 4.10676432 |
| 7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.72078535 |
| 8 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.63987923 |
| 9 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 3.37606663 |
| 10 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.30512599 |
| 11 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.26529995 |
| 12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.17794566 |
| 13 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.11123063 |
| 14 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.86121532 |
| 15 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.83008313 |
| 16 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.80705225 |
| 17 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.70845548 |
| 18 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.58793703 |
| 19 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.58452676 |
| 20 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.57326760 |
| 21 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.53643123 |
| 22 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.52913449 |
| 23 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.24299649 |
| 24 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 2.23953476 |
| 25 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 2.22844583 |
| 26 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.19904007 |
| 27 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.16724987 |
| 28 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.14362124 |
| 29 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.10577722 |
| 30 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.09747875 |
| 31 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.05276926 |
| 32 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.02332622 |
| 33 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.02202548 |
| 34 | MYB_26560356_Chip-Seq_TH2_Human | 1.83321321 |
| 35 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.79379100 |
| 36 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.79094587 |
| 37 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.77420684 |
| 38 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75832152 |
| 39 | MAF_26560356_Chip-Seq_TH1_Human | 1.71594956 |
| 40 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.70944031 |
| 41 | SPI1_23127762_ChIP-Seq_K562_Human | 1.63462834 |
| 42 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.62967837 |
| 43 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.61065434 |
| 44 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.60358010 |
| 45 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.59663679 |
| 46 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.56859043 |
| 47 | MYB_26560356_Chip-Seq_TH1_Human | 1.56831323 |
| 48 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.55488917 |
| 49 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.55117375 |
| 50 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.54837439 |
| 51 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.54248170 |
| 52 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.52084338 |
| 53 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.50788230 |
| 54 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.47375627 |
| 55 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.44859527 |
| 56 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.44052237 |
| 57 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.35799234 |
| 58 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.35597850 |
| 59 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.34831211 |
| 60 | MYC_22102868_ChIP-Seq_BL_Human | 1.34472324 |
| 61 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.34375919 |
| 62 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.31681561 |
| 63 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.31577849 |
| 64 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.28253116 |
| 65 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.27592018 |
| 66 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.27154192 |
| 67 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.25375493 |
| 68 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24943975 |
| 69 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.24814562 |
| 70 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.24434672 |
| 71 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.22838099 |
| 72 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.19172455 |
| 73 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.18273843 |
| 74 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16709132 |
| 75 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.15822986 |
| 76 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.14607003 |
| 77 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.14250237 |
| 78 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.13689310 |
| 79 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.09484907 |
| 80 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.09399642 |
| 81 | GATA3_26560356_Chip-Seq_TH2_Human | 1.09307914 |
| 82 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.05631248 |
| 83 | GATA1_22025678_ChIP-Seq_K562_Human | 1.05558487 |
| 84 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.03914406 |
| 85 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.02694248 |
| 86 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.01756234 |
| 87 | * MAF_26560356_Chip-Seq_TH2_Human | 1.00834348 |
| 88 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.98680041 |
| 89 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.98082186 |
| 90 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.96328362 |
| 91 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.95430471 |
| 92 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.95411787 |
| 93 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.95049862 |
| 94 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.95007247 |
| 95 | * ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.94910859 |
| 96 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.94857982 |
| 97 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.94490081 |
| 98 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.93799536 |
| 99 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.92413309 |
| 100 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.91960395 |
| 101 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.90803801 |
| 102 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.90439850 |
| 103 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.88808521 |
| 104 | P300_27268052_Chip-Seq_Bcells_Human | 0.87839481 |
| 105 | GATA2_19941826_ChIP-Seq_K562_Human | 0.87316224 |
| 106 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.87304275 |
| 107 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.85289130 |
| 108 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.84897918 |
| 109 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.83461421 |
| 110 | GATA1_19941826_ChIP-Seq_K562_Human | 0.83390900 |
| 111 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.81916193 |
| 112 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81471654 |
| 113 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.79718772 |
| 114 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.79045893 |
| 115 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.78512367 |
| 116 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.77632338 |
| 117 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.76023802 |
| 118 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73528946 |
| 119 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.72706075 |
| 120 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.71341954 |
| 121 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.71189199 |
| 122 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.71068149 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.66890188 |
| 2 | MP0003436_decreased_susceptibility_to | 3.81798529 |
| 3 | MP0009785_altered_susceptibility_to | 3.78135889 |
| 4 | MP0002148_abnormal_hypersensitivity_rea | 3.72836872 |
| 5 | MP0002419_abnormal_innate_immunity | 3.20053086 |
| 6 | MP0005025_abnormal_response_to | 3.08910367 |
| 7 | MP0005671_abnormal_response_to | 3.08374542 |
| 8 | MP0005000_abnormal_immune_tolerance | 2.96207985 |
| 9 | MP0005464_abnormal_platelet_physiology | 2.91541382 |
| 10 | MP0003724_increased_susceptibility_to | 2.90070857 |
| 11 | MP0000685_abnormal_immune_system | 2.75798215 |
| 12 | MP0002452_abnormal_antigen_presenting | 2.74621720 |
| 13 | MP0005058_abnormal_lysosome_morphology | 2.67964738 |
| 14 | MP0001800_abnormal_humoral_immune | 2.67652035 |
| 15 | MP0002723_abnormal_immune_serum | 2.64405318 |
| 16 | MP0006082_CNS_inflammation | 2.57876227 |
| 17 | MP0002420_abnormal_adaptive_immunity | 2.47992505 |
| 18 | MP0001819_abnormal_immune_cell | 2.47218804 |
| 19 | MP0003303_peritoneal_inflammation | 2.42372582 |
| 20 | MP0001790_abnormal_immune_system | 2.40982247 |
| 21 | MP0005387_immune_system_phenotype | 2.40982247 |
| 22 | MP0005174_abnormal_tail_pigmentation | 2.24530876 |
| 23 | MP0002396_abnormal_hematopoietic_system | 2.10268885 |
| 24 | MP0003191_abnormal_cellular_cholesterol | 2.05087818 |
| 25 | MP0004510_myositis | 2.01298704 |
| 26 | MP0001533_abnormal_skeleton_physiology | 1.97148811 |
| 27 | MP0002405_respiratory_system_inflammati | 1.96438894 |
| 28 | MP0002398_abnormal_bone_marrow | 1.96316402 |
| 29 | MP0001853_heart_inflammation | 1.93301820 |
| 30 | MP0000716_abnormal_immune_system | 1.90771679 |
| 31 | MP0001845_abnormal_inflammatory_respons | 1.87191990 |
| 32 | MP0001545_abnormal_hematopoietic_system | 1.85710763 |
| 33 | MP0005397_hematopoietic_system_phenotyp | 1.85710763 |
| 34 | MP0000343_altered_response_to | 1.83394428 |
| 35 | MP0004808_abnormal_hematopoietic_stem | 1.81792971 |
| 36 | MP0010155_abnormal_intestine_physiology | 1.78363383 |
| 37 | MP0000689_abnormal_spleen_morphology | 1.77047811 |
| 38 | MP0009379_abnormal_foot_pigmentation | 1.72106009 |
| 39 | MP0009333_abnormal_splenocyte_physiolog | 1.67759992 |
| 40 | MP0002429_abnormal_blood_cell | 1.66001339 |
| 41 | MP0000465_gastrointestinal_hemorrhage | 1.64766560 |
| 42 | MP0008469_abnormal_protein_level | 1.64306710 |
| 43 | MP0009764_decreased_sensitivity_to | 1.62909213 |
| 44 | MP0002722_abnormal_immune_system | 1.62098042 |
| 45 | MP0009278_abnormal_bone_marrow | 1.56983343 |
| 46 | MP0003172_abnormal_lysosome_physiology | 1.55895287 |
| 47 | MP0009840_abnormal_foam_cell | 1.45636470 |
| 48 | MP0003075_altered_response_to | 1.44348226 |
| 49 | MP0005310_abnormal_salivary_gland | 1.40142467 |
| 50 | MP0003763_abnormal_thymus_physiology | 1.37578017 |
| 51 | MP0000490_abnormal_crypts_of | 1.34166092 |
| 52 | MP0003806_abnormal_nucleotide_metabolis | 1.33669518 |
| 53 | MP0002166_altered_tumor_susceptibility | 1.33237620 |
| 54 | MP0002095_abnormal_skin_pigmentation | 1.31543109 |
| 55 | MP0003866_abnormal_defecation | 1.31288901 |
| 56 | MP0000015_abnormal_ear_pigmentation | 1.24704371 |
| 57 | MP0002006_tumorigenesis | 1.20790483 |
| 58 | MP0008260_abnormal_autophagy | 1.17039717 |
| 59 | MP0001851_eye_inflammation | 1.15778129 |
| 60 | MP0005075_abnormal_melanosome_morpholog | 1.14420260 |
| 61 | MP0002998_abnormal_bone_remodeling | 1.12516727 |
| 62 | MP0003828_pulmonary_edema | 1.11958545 |
| 63 | MP0002277_abnormal_respiratory_mucosa | 1.11067190 |
| 64 | MP0001873_stomach_inflammation | 1.07492181 |
| 65 | MP0003183_abnormal_peptide_metabolism | 1.02642738 |
| 66 | MP0005166_decreased_susceptibility_to | 1.01595483 |
| 67 | MP0000858_altered_metastatic_potential | 1.01256170 |
| 68 | MP0003448_altered_tumor_morphology | 1.01175933 |
| 69 | MP0004947_skin_inflammation | 1.00313133 |
| 70 | MP0002138_abnormal_hepatobiliary_system | 0.99922445 |
| 71 | MP0001986_abnormal_taste_sensitivity | 0.99110245 |
| 72 | MP0004147_increased_porphyrin_level | 0.98552288 |
| 73 | MP0004381_abnormal_hair_follicle | 0.97713068 |
| 74 | MP0000604_amyloidosis | 0.95381088 |
| 75 | MP0002254_reproductive_system_inflammat | 0.95172453 |
| 76 | MP0000703_abnormal_thymus_morphology | 0.94625293 |
| 77 | MP0002933_joint_inflammation | 0.92595911 |
| 78 | MP0009763_increased_sensitivity_to | 0.90484453 |
| 79 | MP0005409_darkened_coat_color | 0.90337208 |
| 80 | MP0003186_abnormal_redox_activity | 0.88520315 |
| 81 | MP0005390_skeleton_phenotype | 0.88106803 |
| 82 | MP0003656_abnormal_erythrocyte_physiolo | 0.87468342 |
| 83 | MP0010368_abnormal_lymphatic_system | 0.87434275 |
| 84 | MP0005167_abnormal_blood-brain_barrier | 0.87109971 |
| 85 | MP0005164_abnormal_response_to | 0.82813789 |
| 86 | MP0003878_abnormal_ear_physiology | 0.81797704 |
| 87 | MP0005377_hearing/vestibular/ear_phenot | 0.81797704 |
| 88 | MP0009765_abnormal_xenobiotic_induced | 0.80789519 |
| 89 | MP0002638_abnormal_pupillary_reflex | 0.78964570 |
| 90 | MP0005451_abnormal_body_composition | 0.77833607 |
| 91 | MP0001663_abnormal_digestive_system | 0.76991896 |
| 92 | MP0000249_abnormal_blood_vessel | 0.76188247 |
| 93 | MP0006054_spinal_hemorrhage | 0.70049900 |
| 94 | MP0000569_abnormal_digit_pigmentation | 0.69447620 |
| 95 | MP0002132_abnormal_respiratory_system | 0.65183200 |
| 96 | MP0003795_abnormal_bone_structure | 0.65177653 |
| 97 | MP0005083_abnormal_biliary_tract | 0.64788591 |
| 98 | MP0004782_abnormal_surfactant_physiolog | 0.63598230 |
| 99 | MP0006292_abnormal_olfactory_placode | 0.62679570 |
| 100 | MP0000681_abnormal_thyroid_gland | 0.60207463 |
| 101 | MP0003638_abnormal_response/metabolism_ | 0.59845247 |
| 102 | MP0002653_abnormal_ependyma_morphology | 0.59146161 |
| 103 | MP0004130_abnormal_muscle_cell | 0.59118987 |
| 104 | MP0005319_abnormal_enzyme/_coenzyme | 0.58549243 |
| 105 | MP0004883_abnormal_blood_vessel | 0.58111535 |
| 106 | MP0002019_abnormal_tumor_incidence | 0.57606381 |
| 107 | MP0003195_calcinosis | 0.56423866 |
| 108 | MP0002693_abnormal_pancreas_physiology | 0.55435501 |
| 109 | MP0008873_increased_physiological_sensi | 0.55399225 |
| 110 | MP0003011_delayed_dark_adaptation | 0.55051295 |
| 111 | MP0001879_abnormal_lymphatic_vessel | 0.54650928 |
| 112 | MP0003300_gastrointestinal_ulcer | 0.54266339 |
| 113 | MP0008874_decreased_physiological_sensi | 0.53970038 |
| 114 | MP0003045_fibrosis | 0.52977171 |
| 115 | MP0005084_abnormal_gallbladder_morpholo | 0.52753189 |
| 116 | MP0002136_abnormal_kidney_physiology | 0.52635562 |
| 117 | MP0008004_abnormal_stomach_pH | 0.51571296 |
| 118 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.50166736 |
| 119 | MP0003690_abnormal_glial_cell | 0.49465962 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 6.75529097 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 6.09324051 |
| 3 | Eczematoid dermatitis (HP:0000976) | 5.63128193 |
| 4 | Myositis (HP:0100614) | 4.56495024 |
| 5 | Vacuolated lymphocytes (HP:0001922) | 4.41823485 |
| 6 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.40893156 |
| 7 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.39841744 |
| 8 | Abnormality of macrophages (HP:0004311) | 4.28804078 |
| 9 | Thrombocytosis (HP:0001894) | 4.23198333 |
| 10 | Recurrent skin infections (HP:0001581) | 4.01423486 |
| 11 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.96951482 |
| 12 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.90553581 |
| 13 | Abnormal number of erythroid precursors (HP:0012131) | 3.74610145 |
| 14 | Obstructive lung disease (HP:0006536) | 3.70645321 |
| 15 | Chronic obstructive pulmonary disease (HP:0006510) | 3.70645321 |
| 16 | Increased cerebral lipofuscin (HP:0011813) | 3.68922400 |
| 17 | Gastrointestinal infarctions (HP:0005244) | 3.68359596 |
| 18 | Mediastinal lymphadenopathy (HP:0100721) | 3.67401414 |
| 19 | Reticulocytopenia (HP:0001896) | 3.61482122 |
| 20 | Systemic lupus erythematosus (HP:0002725) | 3.54628117 |
| 21 | Petechiae (HP:0000967) | 3.54483637 |
| 22 | Recurrent fungal infections (HP:0002841) | 3.48107874 |
| 23 | Spontaneous hematomas (HP:0007420) | 3.47454890 |
| 24 | Prolonged bleeding time (HP:0003010) | 3.45894798 |
| 25 | Orchitis (HP:0100796) | 3.39727643 |
| 26 | Cellulitis (HP:0100658) | 3.28876232 |
| 27 | IgM deficiency (HP:0002850) | 3.26694495 |
| 28 | Agnosia (HP:0010524) | 3.19769582 |
| 29 | Stomatitis (HP:0010280) | 3.19133266 |
| 30 | Meningitis (HP:0001287) | 3.18813183 |
| 31 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.17531461 |
| 32 | T lymphocytopenia (HP:0005403) | 3.15794569 |
| 33 | Recurrent viral infections (HP:0004429) | 3.07418143 |
| 34 | Abnormality of T cell number (HP:0011839) | 3.06864205 |
| 35 | Epistaxis (HP:0000421) | 3.05571425 |
| 36 | Increased IgE level (HP:0003212) | 3.01671365 |
| 37 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.00532490 |
| 38 | Hypochromic microcytic anemia (HP:0004840) | 2.97448585 |
| 39 | Optic neuritis (HP:0100653) | 2.95003261 |
| 40 | Retrobulbar optic neuritis (HP:0100654) | 2.95003261 |
| 41 | Glomerulonephritis (HP:0000099) | 2.88849706 |
| 42 | Gingivitis (HP:0000230) | 2.88816924 |
| 43 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.87912805 |
| 44 | Recurrent cutaneous fungal infections (HP:0011370) | 2.87912805 |
| 45 | Chronic otitis media (HP:0000389) | 2.87086097 |
| 46 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.85107973 |
| 47 | Amyloidosis (HP:0011034) | 2.82683212 |
| 48 | Axonal loss (HP:0003447) | 2.82033752 |
| 49 | Basal ganglia calcification (HP:0002135) | 2.81368540 |
| 50 | Disinhibition (HP:0000734) | 2.80449402 |
| 51 | Vasculitis (HP:0002633) | 2.77992337 |
| 52 | Interstitial pulmonary disease (HP:0006530) | 2.77690323 |
| 53 | Abnormality of T cell physiology (HP:0011840) | 2.76572749 |
| 54 | Pallor (HP:0000980) | 2.75899038 |
| 55 | Hypochromic anemia (HP:0001931) | 2.75292000 |
| 56 | Loss of speech (HP:0002371) | 2.73736980 |
| 57 | Pulmonary embolism (HP:0002204) | 2.71748450 |
| 58 | Episodic fever (HP:0001954) | 2.70635971 |
| 59 | Abnormality of the prostate (HP:0008775) | 2.70420474 |
| 60 | Inflammation of the large intestine (HP:0002037) | 2.69788952 |
| 61 | Anorexia (HP:0002039) | 2.69711535 |
| 62 | Panhypogammaglobulinemia (HP:0003139) | 2.67226854 |
| 63 | Prostate neoplasm (HP:0100787) | 2.65908576 |
| 64 | Gastrointestinal inflammation (HP:0004386) | 2.62539654 |
| 65 | Pustule (HP:0200039) | 2.59407298 |
| 66 | Colitis (HP:0002583) | 2.58870038 |
| 67 | Gangrene (HP:0100758) | 2.57730130 |
| 68 | Increased IgM level (HP:0003496) | 2.55682966 |
| 69 | Purpura (HP:0000979) | 2.55216424 |
| 70 | Impaired platelet aggregation (HP:0003540) | 2.54532031 |
| 71 | Abnormal platelet function (HP:0011869) | 2.54532031 |
| 72 | Periodontitis (HP:0000704) | 2.53888866 |
| 73 | Autoimmune thrombocytopenia (HP:0001973) | 2.48468896 |
| 74 | Granulocytopenia (HP:0001913) | 2.46422310 |
| 75 | Urticaria (HP:0001025) | 2.46413888 |
| 76 | Abnormality of the pleura (HP:0002103) | 2.45212867 |
| 77 | Upper motor neuron abnormality (HP:0002127) | 2.38733897 |
| 78 | Aplastic anemia (HP:0001915) | 2.33907401 |
| 79 | Agammaglobulinemia (HP:0004432) | 2.31093722 |
| 80 | Gingival bleeding (HP:0000225) | 2.29755686 |
| 81 | Macrocytic anemia (HP:0001972) | 2.29178994 |
| 82 | Vertigo (HP:0002321) | 2.28161154 |
| 83 | Reduced antithrombin III activity (HP:0001976) | 2.28088844 |
| 84 | Sepsis (HP:0100806) | 2.27844009 |
| 85 | Arterial thrombosis (HP:0004420) | 2.26356939 |
| 86 | Hypergammaglobulinemia (HP:0010702) | 2.24124001 |
| 87 | Hepatosplenomegaly (HP:0001433) | 2.23902127 |
| 88 | Osteomyelitis (HP:0002754) | 2.22446142 |
| 89 | Polyneuropathy (HP:0001271) | 2.22161909 |
| 90 | Dysostosis multiplex (HP:0000943) | 2.22066083 |
| 91 | Albinism (HP:0001022) | 2.21061223 |
| 92 | Recurrent lower respiratory tract infections (HP:0002783) | 2.17777694 |
| 93 | Recurrent pneumonia (HP:0006532) | 2.14592642 |
| 94 | Glomerulopathy (HP:0100820) | 2.13334476 |
| 95 | Encephalitis (HP:0002383) | 2.11857905 |
| 96 | Eosinophilia (HP:0001880) | 2.11769947 |
| 97 | Joint hemorrhage (HP:0005261) | 2.11211300 |
| 98 | Abnormality of iron homeostasis (HP:0011031) | 2.10180659 |
| 99 | Leukocytosis (HP:0001974) | 2.09138367 |
| 100 | Chest pain (HP:0100749) | 2.08422239 |
| 101 | Thyroiditis (HP:0100646) | 2.08074489 |
| 102 | Hemoptysis (HP:0002105) | 2.07954830 |
| 103 | Mutism (HP:0002300) | 2.06924881 |
| 104 | Abnormality of T cells (HP:0002843) | 2.06838825 |
| 105 | Type I transferrin isoform profile (HP:0003642) | 2.05588153 |
| 106 | Microcytic anemia (HP:0001935) | 2.05463234 |
| 107 | Abnormality of the endocardium (HP:0004306) | 2.05023302 |
| 108 | Abnormality of eosinophils (HP:0001879) | 2.04802215 |
| 109 | Abnormality of the nasal mucosa (HP:0000433) | 2.03785698 |
| 110 | Keratoconjunctivitis sicca (HP:0001097) | 2.02804970 |
| 111 | Abnormality of the pericardium (HP:0001697) | 2.01949963 |
| 112 | Peritonitis (HP:0002586) | 2.01688917 |
| 113 | Keratitis (HP:0000491) | 1.99541523 |
| 114 | Premature loss of primary teeth (HP:0006323) | 1.96620217 |
| 115 | Pulmonary infiltrates (HP:0002113) | 1.95740258 |
| 116 | Acne (HP:0001061) | 1.93870268 |
| 117 | IgG deficiency (HP:0004315) | 1.92916197 |
| 118 | Lymphopenia (HP:0001888) | 1.92542332 |
| 119 | Nephritis (HP:0000123) | 1.92009491 |
| 120 | Poor head control (HP:0002421) | 1.91301388 |
| 121 | Progressive neurologic deterioration (HP:0002344) | 1.89993017 |
| 122 | Hematochezia (HP:0002573) | 1.89916886 |
| 123 | Abnormality of glycolipid metabolism (HP:0010969) | 1.89603586 |
| 124 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.89603586 |
| 125 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.89603586 |
| 126 | Exertional dyspnea (HP:0002875) | 1.89468594 |
| 127 | Menorrhagia (HP:0000132) | 1.88452859 |
| 128 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.88026703 |
| 129 | Arthralgia (HP:0002829) | 1.87093312 |
| 130 | Gastrointestinal stroma tumor (HP:0100723) | 1.86357387 |
| 131 | Recurrent bronchitis (HP:0002837) | 1.85912077 |
| 132 | Severe combined immunodeficiency (HP:0004430) | 1.85848439 |
| 133 | Skin ulcer (HP:0200042) | 1.85227262 |
| 134 | Increased serum ferritin (HP:0003281) | 1.84626345 |
| 135 | Keratoconjunctivitis (HP:0001096) | 1.84302072 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BLK | 4.23629848 |
| 2 | RIPK4 | 3.15791047 |
| 3 | TGFBR2 | 3.03355354 |
| 4 | MAP4K1 | 2.99621203 |
| 5 | KIT | 2.97665260 |
| 6 | IRAK4 | 2.90321029 |
| 7 | NME2 | 2.72584647 |
| 8 | BTK | 2.42002375 |
| 9 | MAP2K3 | 2.41356693 |
| 10 | TEC | 2.38347162 |
| 11 | TBK1 | 2.24037009 |
| 12 | MUSK | 2.10185273 |
| 13 | TXK | 2.09227878 |
| 14 | TGFBR1 | 2.07612584 |
| 15 | TYK2 | 2.01910321 |
| 16 | IKBKE | 1.91521839 |
| 17 | ZAP70 | 1.82613596 |
| 18 | MAP3K14 | 1.80456682 |
| 19 | JAK3 | 1.77907526 |
| 20 | SYK | 1.75594823 |
| 21 | IRAK3 | 1.71725736 |
| 22 | IKBKB | 1.71441572 |
| 23 | MATK | 1.70291692 |
| 24 | MAP3K12 | 1.61070791 |
| 25 | CSF1R | 1.59972500 |
| 26 | GRK7 | 1.57539404 |
| 27 | FES | 1.55015486 |
| 28 | TNIK | 1.52652136 |
| 29 | LYN | 1.51328246 |
| 30 | CDK19 | 1.47169450 |
| 31 | TAOK1 | 1.44409307 |
| 32 | PIM2 | 1.41844547 |
| 33 | ACVR1B | 1.32855725 |
| 34 | CAMKK2 | 1.31633074 |
| 35 | ERN1 | 1.29058475 |
| 36 | MARK3 | 1.20877221 |
| 37 | PRPF4B | 1.18181472 |
| 38 | LCK | 1.15703564 |
| 39 | SIK2 | 1.13496631 |
| 40 | HCK | 1.12759235 |
| 41 | TAOK3 | 1.10552040 |
| 42 | CSK | 1.10506072 |
| 43 | TIE1 | 1.07709408 |
| 44 | BMPR1B | 1.05826505 |
| 45 | FLT3 | 1.05556623 |
| 46 | RPS6KA4 | 1.01355541 |
| 47 | PIM1 | 0.98689054 |
| 48 | CLK1 | 0.98510372 |
| 49 | CAMKK1 | 0.97295171 |
| 50 | SIK3 | 0.96044417 |
| 51 | WEE1 | 0.95465858 |
| 52 | MAP3K1 | 0.90274925 |
| 53 | EIF2AK2 | 0.88962511 |
| 54 | STK16 | 0.88557030 |
| 55 | CDK8 | 0.86296904 |
| 56 | EEF2K | 0.85321612 |
| 57 | PIK3CG | 0.85024740 |
| 58 | IRAK1 | 0.84165319 |
| 59 | NLK | 0.82640292 |
| 60 | MAPKAPK5 | 0.82225728 |
| 61 | MAP3K3 | 0.81887242 |
| 62 | TESK2 | 0.81583465 |
| 63 | MOS | 0.80972392 |
| 64 | KDR | 0.79957383 |
| 65 | BRSK2 | 0.79650685 |
| 66 | ADRBK2 | 0.79537223 |
| 67 | PASK | 0.77359791 |
| 68 | TAOK2 | 0.75049719 |
| 69 | TRPM7 | 0.74065803 |
| 70 | DYRK3 | 0.71715049 |
| 71 | PRKCQ | 0.71452784 |
| 72 | JAK1 | 0.69854610 |
| 73 | PRKG2 | 0.69219121 |
| 74 | TNK2 | 0.68716918 |
| 75 | EPHB1 | 0.68689796 |
| 76 | YES1 | 0.68406884 |
| 77 | STK10 | 0.67006166 |
| 78 | EIF2AK3 | 0.66972738 |
| 79 | MKNK1 | 0.66017559 |
| 80 | JAK2 | 0.65614216 |
| 81 | FGR | 0.65056154 |
| 82 | LRRK2 | 0.64804850 |
| 83 | MAP2K6 | 0.64384314 |
| 84 | MARK2 | 0.64201068 |
| 85 | PDPK1 | 0.63601467 |
| 86 | FYN | 0.63344479 |
| 87 | CAMK1 | 0.63020812 |
| 88 | MAP3K7 | 0.62038755 |
| 89 | MAPK7 | 0.61090051 |
| 90 | DAPK2 | 0.59235467 |
| 91 | MYLK | 0.58535251 |
| 92 | PRKCD | 0.58230137 |
| 93 | PRKD2 | 0.58181804 |
| 94 | ABL2 | 0.57808625 |
| 95 | MAPK4 | 0.57221470 |
| 96 | MAPK12 | 0.56446223 |
| 97 | IRAK2 | 0.55158654 |
| 98 | HIPK2 | 0.54338390 |
| 99 | CHUK | 0.53326063 |
| 100 | KSR2 | 0.51988395 |
| 101 | MST4 | 0.51458860 |
| 102 | RPS6KB2 | 0.50241387 |
| 103 | PTK2B | 0.49668853 |
| 104 | MAP2K2 | 0.48995008 |
| 105 | STK11 | 0.46093647 |
| 106 | PAK4 | 0.46044415 |
| 107 | PTK6 | 0.44811252 |
| 108 | RPS6KA5 | 0.44186457 |
| 109 | ITK | 0.44079149 |
| 110 | CCNB1 | 0.43241736 |
| 111 | CDC42BPA | 0.42989695 |
| 112 | VRK1 | 0.42615667 |
| 113 | MAP3K6 | 0.39916941 |
| 114 | SCYL2 | 0.39726047 |
| 115 | MAP3K5 | 0.39509422 |
| 116 | MAP3K13 | 0.39396390 |
| 117 | MAPKAPK2 | 0.37765258 |
| 118 | RPS6KA6 | 0.37521404 |
| 119 | MKNK2 | 0.37275799 |
| 120 | GRK6 | 0.35845787 |
| 121 | TLK1 | 0.35511121 |
| 122 | FRK | 0.34758976 |
| 123 | ABL1 | 0.34115147 |
| 124 | MAP3K11 | 0.33787692 |
| 125 | STK4 | 0.33591942 |
| 126 | BMPR2 | 0.32108389 |
| 127 | MAP2K4 | 0.30159950 |
| 128 | DYRK1B | 0.28814463 |
| 129 | PDK1 | 0.28206536 |
| 130 | NEK9 | 0.27345219 |
| 131 | RPS6KL1 | 0.26977456 |
| 132 | RPS6KC1 | 0.26977456 |
| 133 | STK38 | 0.23180511 |
| 134 | RPS6KA1 | 0.23036381 |
| 135 | ADRBK1 | 0.21477375 |
| 136 | MAP3K2 | 0.21295183 |
| 137 | OXSR1 | 0.18577545 |
| 138 | PRKCZ | 0.18244261 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 3.85278194 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.20794117 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.99642928 |
| 4 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.71933685 |
| 5 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.36144260 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.33653200 |
| 7 | Pertussis_Homo sapiens_hsa05133 | 2.11747270 |
| 8 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.09758261 |
| 9 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.08878408 |
| 10 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.02533846 |
| 11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.98499560 |
| 12 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.95691730 |
| 13 | Measles_Homo sapiens_hsa05162 | 1.95119159 |
| 14 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.92698126 |
| 15 | Asthma_Homo sapiens_hsa05310 | 1.92068909 |
| 16 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.87777002 |
| 17 | Other glycan degradation_Homo sapiens_hsa00511 | 1.87501127 |
| 18 | Tuberculosis_Homo sapiens_hsa05152 | 1.80998525 |
| 19 | Legionellosis_Homo sapiens_hsa05134 | 1.78653447 |
| 20 | Allograft rejection_Homo sapiens_hsa05330 | 1.75131644 |
| 21 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.74308651 |
| 22 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.70255922 |
| 23 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.67550007 |
| 24 | Malaria_Homo sapiens_hsa05144 | 1.66764452 |
| 25 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.66046310 |
| 26 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.63859481 |
| 27 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.59562215 |
| 28 | Lysosome_Homo sapiens_hsa04142 | 1.58179396 |
| 29 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.56705958 |
| 30 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.54476432 |
| 31 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.49429126 |
| 32 | Salmonella infection_Homo sapiens_hsa05132 | 1.47426521 |
| 33 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.47224711 |
| 34 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.41991622 |
| 35 | DNA replication_Homo sapiens_hsa03030 | 1.40047918 |
| 36 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.39872705 |
| 37 | Influenza A_Homo sapiens_hsa05164 | 1.39006295 |
| 38 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.37397447 |
| 39 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.26347502 |
| 40 | Shigellosis_Homo sapiens_hsa05131 | 1.24855365 |
| 41 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.22953283 |
| 42 | Platelet activation_Homo sapiens_hsa04611 | 1.21574329 |
| 43 | Phagosome_Homo sapiens_hsa04145 | 1.20176403 |
| 44 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.17835264 |
| 45 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.12405522 |
| 46 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.12363196 |
| 47 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.12172834 |
| 48 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.09624235 |
| 49 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.04414132 |
| 50 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.03891455 |
| 51 | Apoptosis_Homo sapiens_hsa04210 | 1.02857684 |
| 52 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.94462279 |
| 53 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.91485968 |
| 54 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.91099403 |
| 55 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.89224458 |
| 56 | Hepatitis B_Homo sapiens_hsa05161 | 0.89046097 |
| 57 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.85793957 |
| 58 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.84814830 |
| 59 | Base excision repair_Homo sapiens_hsa03410 | 0.78560240 |
| 60 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.78358339 |
| 61 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.76290873 |
| 62 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.74940860 |
| 63 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.73461072 |
| 64 | Protein export_Homo sapiens_hsa03060 | 0.72058120 |
| 65 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.71932993 |
| 66 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.67682883 |
| 67 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.67444563 |
| 68 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.66850055 |
| 69 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.65205019 |
| 70 | Homologous recombination_Homo sapiens_hsa03440 | 0.64853783 |
| 71 | Hepatitis C_Homo sapiens_hsa05160 | 0.64445930 |
| 72 | Mismatch repair_Homo sapiens_hsa03430 | 0.64148152 |
| 73 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.62976495 |
| 74 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.62678337 |
| 75 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.61007398 |
| 76 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.58722426 |
| 77 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.58122643 |
| 78 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.54404179 |
| 79 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.54136404 |
| 80 | Endocytosis_Homo sapiens_hsa04144 | 0.52401567 |
| 81 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.51593762 |
| 82 | RNA polymerase_Homo sapiens_hsa03020 | 0.50567890 |
| 83 | Proteasome_Homo sapiens_hsa03050 | 0.50557342 |
| 84 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.50549060 |
| 85 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.50353362 |
| 86 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.47724592 |
| 87 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.47144815 |
| 88 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.44095424 |
| 89 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.43566317 |
| 90 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.41640294 |
| 91 | HTLV-I infection_Homo sapiens_hsa05166 | 0.39998916 |
| 92 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.39108140 |
| 93 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.38425030 |
| 94 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.38218436 |
| 95 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.37585215 |
| 96 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.37184567 |
| 97 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.36490960 |
| 98 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.36390269 |
| 99 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.35992125 |
| 100 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.35584155 |
| 101 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.35309812 |
| 102 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.34662278 |
| 103 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.34491220 |
| 104 | Galactose metabolism_Homo sapiens_hsa00052 | 0.34048978 |
| 105 | Viral myocarditis_Homo sapiens_hsa05416 | 0.33880382 |
| 106 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.33650796 |
| 107 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.32418008 |
| 108 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.32189647 |
| 109 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.31051464 |
| 110 | Purine metabolism_Homo sapiens_hsa00230 | 0.30373341 |
| 111 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.30248774 |
| 112 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.29928299 |
| 113 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.29914073 |
| 114 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.27986702 |
| 115 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.27650165 |
| 116 | Spliceosome_Homo sapiens_hsa03040 | 0.25902104 |
| 117 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.25472662 |
| 118 | Amoebiasis_Homo sapiens_hsa05146 | 0.25128130 |
| 119 | Insulin resistance_Homo sapiens_hsa04931 | 0.23424535 |
| 120 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.21443067 |
| 121 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.20657357 |
| 122 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.20231174 |
| 123 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.19432582 |
| 124 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.19237423 |
| 125 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.16956603 |
| 126 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.15522593 |

